# Characterizing Clinical and Pharmacological Neuroimaging Biomarkers

> **NCT03842800** · EARLY_PHASE1 · COMPLETED · sponsor: **Yale University** · enrollment: 143 (actual)

## Conditions studied

- Cognitive Impairment

## Interventions

- **OTHER:** MRI
- **DRUG:** Ketamine

## Key facts

- **NCT ID:** NCT03842800
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04-01
- **Primary completion:** 2018-08-31
- **Final completion:** 2018-08-31
- **Target enrollment:** 143 (ACTUAL)
- **Last updated:** 2020-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03842800

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03842800, "Characterizing Clinical and Pharmacological Neuroimaging Biomarkers". Retrieved via AI Analytics 2026-08-24 from https://api.ai-analytics.org/clinical/NCT03842800. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*